Banking & Financial Services
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
Glenmark Pharmaceuticals News
How Glenmark Pharma won this Candid Powder battle against lookalike rival
Thu, May 24, 2018
Pharma company Glenmark Pharmaceuticals, which manufactures and sells Candid Dusting Powder, has recently won a trademark and copyright battle in the Bombay High Court, against a lookalike brand, which sold a dusting powder by the name ‘Candidat’.
Post GST domestic pharma companies to face headwinds in 1HFY18
Mon, Jun 05, 2017
It has been a long and dreary quarter for pharmaceutical companies in Q4 wherein most posted a decline in net profit and things are not looking too good for the Indian pharma companies in the first half of FY18 as well.
Glenmark Pharmaceuticals receives ANDA approval for Atomoxetine capsule
Wed, May 31, 2017
The Glenmark Pharmaceuticals has been granted permission by the United States Food & Drug Administration (U.S. FDA) for Atomoxetine capsules.
Glenmark receives tentative approval Fingolimod Capsules; shares down
Mon, Mar 20, 2017
Glenmark’s current portfolio consists of 112 products authorized for distribution in the US marketplace.
Glenmark Pharma's Q3 net profit rise by 143% to Rs 477 crore
Thu, Feb 02, 2017
The company's total income increased to Rs 2549.5 crore in Q3FY17 as compared to Rs 1780.4 crore in Q3FY16.
India Inc's overseas borrowings down 44% to $1.2 billion in July
Fri, Aug 26, 2016
India Inc's overseas borrowings fell by 44% to $1.2 billion (nearly Rs 7,983.3 crore) in July this year as against $2.14 billion (nearly Rs 14,236.9 crore) in the same period a year ago.
Glenmark Pharma net profit rise 24%; Europe segment major contributor
Fri, Aug 12, 2016
Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals said, “In the first quarter of this financial year, nearly all our businesses have rebounded strongly and we have seen good growth across all operating regions except Latam.